Eton Pharmaceuticals Inc ETON
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
Trading Information
- Previous Close Price
- $61.45
- Day Range
- $61.01–65.18
- 52-Week Range
- $14.27–70.64
- Bid/Ask
- $62.00 / $64.50
- Shares Outstanding
- 28.84M
- Market Cap
- $1.84B
- Volume/Avg
- 601,302 / 620,072
Key Statistics
- Price/Earnings (Normalized)
- 67.54
- Price/Sales
- 14.18
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has eight commercial rare disease products, INCRELEX, ALKINDI SPRINKLE, KHINDIVITM, GALZIN, PKU GOLIKE, Carglumic Acid, Betaine Anhydrous and Nitisinone. It also has five additional product candidates in late-stage development: ET-600, Amglidia, ET-700, ET-800 and ZENEO hydrocortisone autoinjector.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Growth
- Total Number of Employees
- 44
- Website
- https://www.etonpharma.com
Valuation
Metric | ETON |
|---|---|
Price/Earnings (Normalized) | 67.54 |
Price/Book Value | 21.20 |
Price/Sales | 14.18 |
Price/Cash Flow | 34.95 |
Price/Earnings
ETON
Financial Strength
Metric | ETON |
|---|---|
Quick Ratio | 1.52 |
Current Ratio | 1.79 |
Interest Coverage | 11.23 |
Quick Ratio
ETON
Profitability
Metric | ETON |
|---|---|
Return on Assets (Normalized) | 35.86% |
Return on Equity (Normalized) | 95.34% |
Return on Invested Capital (Normalized) | 60.34% |
Return on Assets
ETON
Drug Manufacturers - Specialty & Generic Industry Comparables
1-Day Chart | Name | Price | Morningstar Rating for Stocks | Capital Allocation | Economic Moat | Market Cap |
|---|---|---|---|---|---|---|
| Merck KGaA ADR MKKGY | LOCK|H#bxjl%< | LOCK|$Qlr$ | $72B | |||
| Teva Pharmaceutical Industries Ltd TEVA | LOCK|JjD>q<# | LOCK|NQxY | $51B | |||
| Haleon PLC ADR HLN | LOCK|DJj>Wz< | LOCK|t! | $40B | |||
| Zoetis Inc Class A ZTS | LOCK|vH&xy%d | LOCK|$& | $34B | |||
| Viatris Inc VTRS | LOCK|@v<B<^! | LOCK|ldt | $24B | |||
| Elanco Animal Health Inc ELAN | LOCK|@% | LOCK|!$ | $13B | |||
| Dr Reddy's Laboratories Ltd ADR RDY | LOCK|bgjDB<# | LOCK|SK | $12B | |||
| Hims & Hers Health Inc Ordinary Shares - Class A HIMS | LOCK|@lJ&%># | LOCK|cD | $5B | |||
| Perrigo Co PLC PRGO | LOCK|#!CT>?J | LOCK|JJ | $2B | |||
| Prestige Consumer Healthcare Inc PBH | LOCK|kJbKST | LOCK|RMSX | $2B |
United States